Answers are grounded in this paper and cite their sources.
Case reveals neutrophilia in squamous cell lung cancer, suggesting G-CSF may mislead diagnosis and treatment.
This is a case of squamous cell cancer (SCC) of the lung masquerading as a haematologic malignancy with marked neutrophilia ultimately found to have a ROS1 rearrangement in a non-smoker patient. The patient achieved a near complete response to therapy and prompt resolution of neutrophilia after being started on a c-ros oncogene 1 (ROS1)-targeted tyrosine kinase inhibitor. Profound neutrophilia can be a presenting sign of granulocyte colony-stimulating factor (G-CSF) secreting SCC of the lung. This is significant because G-CSF can potentially masquerade as alternative diagnoses, delaying appropriate treatment. Neutrophilia may also be a potential tool for disease monitoring in such cases. Furthermore, this case describes a rare presentation of a ROS1 alteration in SCC of the lung. This illustrates the importance of routine comprehensive genomic profiling in lung cancer patients regardless of histology and smoking status.
No takes yet. Share an insight, caveat, or question.
Garg et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: